finance
Healwell AI Experiences Significant Revenue Growth in First Quarter
Healwell AI has announced its financial performance for the first quarter, revealing a substantial increase in revenue alongside strategic advancements. The company emphasized its focus on expanding its AI-powered healthcare solutions and market presence.
5/13/2026, 8:31:36 AM
Healwell AI Inc. has released its earnings report for the first fiscal quarter, detailing considerable financial growth and operational developments. For the period ending March 31, the artificial intelligence healthcare firm posted a notable surge in its top-line figures.
According to Seeking Alpha, the company's revenue reached $15.8 million during the initial three months of the year, marking a dramatic increase from the $0.3 million recorded in the same quarter of the previous year. This significant jump underscores the firm's expanding market penetration and the increasing adoption of its technology within the healthcare sector.
The gross profit also saw a substantial rise, climbing to $7.3 million compared to $0.2 million in the first quarter of the prior year. This improvement in gross profit reflects enhanced operational efficiency and a favorable cost structure as the company scales its activities.
Despite the positive revenue and gross profit trends, Healwell AI reported an adjusted EBITDA loss of $4.4 million for the quarter. This figure indicates ongoing investments in research and development, market expansion, and infrastructure, typical for a growth-oriented technology company aiming to capture a larger market share.
The company's net loss attributable to shareholders was reported at $10.9 million, or $0.10 per share. This includes various non-cash expenses and strategic expenditures aimed at future growth. Cash and marketable securities stood at $72 million as of March 31, providing a solid financial foundation for continued operations and strategic initiatives.
During the quarter, Healwell AI also completed its acquisition of Intrahealth, a move that is expected to bolster its product offerings and expand its reach. This strategic acquisition is part of the company's broader effort to consolidate its position in the competitive AI healthcare landscape. Additionally, the company is preparing for its annual meeting of shareholders, scheduled for June 20, where further business updates and future directions are anticipated to be discussed.